DER AKTIONÄR på Twitter: "Online-Apotheke Zur Rose konkretisiert IPO-Pläne - positiver Abstrahleffekt auf Shop Apotheke Europe? https://t.co/AC7RvAMi3i https://t.co/TNcz0fLoR3" / Twitter
![Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity](https://valueandopportunity.files.wordpress.com/2019/03/csm_zurrosegroupfinal_01_70165d445d.jpg)
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
![Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity](https://i.ytimg.com/vi/foCG9wX7eww/maxresdefault.jpg)
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
![Zur Rose Group: DocMorris-Konkurrent Shop Apotheke Europe plant Börsengang in Frankfurt - Erstaunliche Bewertungsvorstellungen - schweizeraktien.net Zur Rose Group: DocMorris-Konkurrent Shop Apotheke Europe plant Börsengang in Frankfurt - Erstaunliche Bewertungsvorstellungen - schweizeraktien.net](https://www.schweizeraktien.net/wp-content/uploads/2016/09/Zur_Rose_Logistik.jpg)